Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity?
Maggi P, De Socio GV, Menzaghi B, Molteni C, Squillace N, Taramasso L, Guastavigna M, Gamboni G, Madeddu G, Vichi F, Cascio A, Sarchi E, Pellicanò G, Martinelli CV, Celesia BM, Valsecchi L, Gulminetti R, Cenderello G, Parisini A, Calza L, Falasca K, Orofino G, Ricci E, Di Biagio A, Bonfanti P. Maggi P, et al. Among authors: squillace n. BMC Infect Dis. 2022 Sep 23;22(1):745. doi: 10.1186/s12879-022-07739-y. BMC Infect Dis. 2022. PMID: 36151508 Free PMC article.
Focal bone lesions in HIV-positive patient treated with tenofovir.
Mangioni D, Bandera A, Muscatello A, Squillace N, Crivellaro C, Guerra L, Messa C, Gori A. Mangioni D, et al. Among authors: squillace n. BMC Infect Dis. 2014 Mar 6;14:131. doi: 10.1186/1471-2334-14-131. BMC Infect Dis. 2014. PMID: 24602357 Free PMC article.
Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: the IMMUNEF clinical trial.
Soria A, Trabattoni D, Squillace N, Rainone V, Gnudi F, Clerici M, Gori A, Bandera A. Soria A, et al. Among authors: squillace n. PLoS One. 2015 Feb 11;10(2):e0117118. doi: 10.1371/journal.pone.0117118. eCollection 2015. PLoS One. 2015. PMID: 25671649 Free PMC article. Clinical Trial.
Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing?
Taramasso L, Ricci E, Celesia BM, Bonfanti P, Quirino T, Squillace N, Nicolini LA, Maggi P, Martinelli C, De Socio GV, Di Biagio A; on behalf CISAI Study Group. Taramasso L, et al. Among authors: squillace n. Clin Res Hepatol Gastroenterol. 2017 Oct;41(5):e76-e79. doi: 10.1016/j.clinre.2017.03.006. Epub 2017 Apr 21. Clin Res Hepatol Gastroenterol. 2017. PMID: 28438572 No abstract available.
Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project.
Squillace N, Ricci E, Quirino T, Gori A, Bandera A, Carenzi L, De Socio GV, Orofino G, Martinelli C, Madeddu G, Rusconi S, Maggi P, Celesia BM, Cordier L, Vichi F, Calza L, Falasca K, Di Biagio A, Pellicanò GF, Bonfanti P; CISAI Study Group. Squillace N, et al. PLoS One. 2017 Jun 20;12(6):e0179254. doi: 10.1371/journal.pone.0179254. eCollection 2017. PLoS One. 2017. PMID: 28632758 Free PMC article.
Cardiovascular risk and dyslipidemia among persons living with HIV: a review.
Maggi P, Di Biagio A, Rusconi S, Cicalini S, D'Abbraccio M, d'Ettorre G, Martinelli C, Nunnari G, Sighinolfi L, Spagnuolo V, Squillace N. Maggi P, et al. Among authors: squillace n. BMC Infect Dis. 2017 Aug 9;17(1):551. doi: 10.1186/s12879-017-2626-z. BMC Infect Dis. 2017. PMID: 28793863 Free PMC article. Review.
99 results